| 1 |
34201962 | Extracellular Sphingosine-1-Phosphate Downstream of EGFR Increases Human Glioblastoma Cell Survival. | 2021 Jun 25 |
2 |
| 2 |
31875307 | Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma. | 2020 Jan |
1 |
| 3 |
32039732 | DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. | 2020 Feb 10 |
3 |
| 4 |
33209885 | Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression. | 2020 Oct |
2 |
| 5 |
33719269 | [Toxic effects of Vitamin C combined with temozolomide on glioma cells and its mechanism]. | 2020 Nov |
1 |
| 6 |
31006910 | Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4-Akt-ERK signalling by inhibiting EGR1-dependent transcription. | 2019 Jun |
1 |
| 7 |
31424680 | Antitumor activity of Cedrelone in temozolomide-resistant human glioma cells is accompanied by mitochondrial mediated apoptosis, inhibition of angiogenesis, cell cycle disruption and modulation of ERK/MAPK signalling pathway. | 2019 May-Jun |
3 |
| 8 |
31492191 | Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma. | 2019 Sep 6 |
2 |
| 9 |
29473317 | MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway. | 2018 Mar |
3 |
| 10 |
30061180 | Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway. | 2018 Oct 31 |
1 |
| 11 |
28617438 | Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling. | 2017 Jun 15 |
1 |
| 12 |
27878252 | Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells. | 2016 Dec |
4 |
| 13 |
25542083 | Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas. | 2015 Mar 28 |
1 |
| 14 |
25093489 | Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway. | 2014 Sep 23 |
1 |